MANE is currently priced at $91.69. The technical outlook is "Strong Sell" based on moving average alignment, RSI, and MACD signals.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.